Dr. Pegan received an annual continuation of funding in the amount of $308,078 from the National Institutes of Health for the project titled, ORIGIN OF THE INNATE IMMUNITY SUPPRESSION CA– USED BY NAIROVIRUS’ PROTEASE ACTIVITY.
He also has been busy publishing, Engineering the Organophosphorus Acid Anhydrolase Enzyme for Increased Catalytic Efficiency and Broadened Stereospecificity on Russian VX. Daczkowski CM, Pegan SD, Harvey SP. Biochemistry. 2015 Oct 20;54(41):6423-33. doi:10.1021/acs.biochem.5b00624. Epub 2015 Oct 6
And…presenting, “A journey into the world of nairovirus ovarian tumor domain proteases and implications for therapeutic discovery,” Mercer University College of Pharmacy, October 19th, 2015.